"RNA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
| Descriptor ID |
D012313
|
| MeSH Number(s) |
D13.444.735
|
| Concept/Terms |
RNA- RNA
- Gene Products, RNA
- RNA Gene Products
- RNA, Non-Polyadenylated
- RNA, Non Polyadenylated
- Non-Polyadenylated RNA
- Non Polyadenylated RNA
- Ribonucleic Acid
- Acid, Ribonucleic
|
Below are MeSH descriptors whose meaning is more general than "RNA".
Below are MeSH descriptors whose meaning is more specific than "RNA".
- RNA
- RNA Isoforms
- RNA Precursors
- RNA, Algal
- RNA, Antisense
- RNA, Archaeal
- RNA, Bacterial
- RNA, Complementary
- RNA, Double-Stranded
- RNA, Fungal
- RNA, Helminth
- RNA, Messenger
- RNA, Neoplasm
- RNA, Nuclear
- RNA, Plant
- RNA, Protozoan
- RNA, Ribosomal
- RNA, Satellite
- RNA, Transfer
- RNA, Untranslated
- RNA, Viral
This graph shows the total number of publications written about "RNA" by people in this website by year, and whether "RNA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA" by people in Profiles.
-
Site-specific regulation of RNA editing with ribose-modified nucleoside analogs in ADAR guide strands. Nucleic Acids Res. 2024 Jul 08; 52(12):6733-6747.
-
PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study. Breast Cancer Res Treat. 2023 Aug; 200(3):337-346.
-
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 06; 10(6):e363-e374.
-
Cohort profile: the South African National Health Laboratory Service (NHLS) National HIV Cohort. BMJ Open. 2022 10 19; 12(10):e066671.
-
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial. J Int AIDS Soc. 2022 06; 25(6):e25905.
-
RNA-based therapy in the management of lipid disorders: a review. Lipids Health Dis. 2022 Apr 23; 21(1):41.
-
Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. J Virol Methods. 2022 04; 302:114471.
-
Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE Trial. Clin Infect Dis. 2021 08 16; 73(4):e1008-e1010.
-
Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes. J Mol Model. 2021 Jan 25; 27(2):49.
-
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. Cell Host Microbe. 2018 06 13; 23(6):845-854.e6.